Austar Lifesciences Limited AULSF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.77% | -1.63% | 0.96% | -64.41% | 0.59% |
| Total Depreciation and Amortization | 1.77% | 1.83% | 0.97% | -3.60% | 0.59% |
| Total Amortization of Deferred Charges | 1.74% | 11.16% | 0.98% | -9.92% | 0.61% |
| Total Other Non-Cash Items | 1.77% | 154.88% | 0.97% | 300.36% | -0.59% |
| Change in Net Operating Assets | -- | -- | 0.97% | -- | -- |
| Cash from Operations | 1.77% | -2.95% | 0.97% | 141.48% | 0.59% |
| Capital Expenditure | -1.77% | -88.38% | -0.97% | -5.84% | -0.59% |
| Sale of Property, Plant, and Equipment | -- | -- | 1.23% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.85% | -188.10% | 0.92% | -83.48% | 0.60% |
| Cash from Investing | -1.77% | -130.47% | -0.97% | -273.66% | -0.58% |
| Total Debt Issued | 0.00% | -59.02% | 0.00% | 47.14% | 0.00% |
| Total Debt Repaid | 0.00% | 30.15% | 0.00% | -29.22% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 36.02% | 0.00% | -8.43% | 0.00% |
| Cash from Financing | -1.77% | -317.35% | -0.97% | 47.90% | -0.59% |
| Foreign Exchange rate Adjustments | -1.78% | -447.35% | -0.84% | -252.48% | -1.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.78% | -128.89% | 0.97% | 3,058.95% | -0.61% |